NCT06035549 Resilience in East Asian Immigrants for Advance Care Planning Discussions
| NCT ID | NCT06035549 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Illinois at Chicago |
| Condition | Neoplasms |
| Study Type | OBSERVATIONAL |
| Enrollment | 84 participants |
| Start Date | 2023-10-27 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 84 participants in total. It began in 2023-10-27 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of the study is to develop a culturally tailored digital resilience-building intervention to help East Asian immigrants engage in advance care planning discussions with their family caregivers.
Eligibility Criteria
Inclusion Criteria for Religious Leaders: * Age ≥ 18 years * Serving as a chaplain or religious leader at a healthcare setting or religious organization * Having experience providing pastoral or spiritual care to Chinese, Japanese, and Korean Americans in the US * Being able to read and respond to questions in English, Mandarin, Cantonese, Japanese, or Korean. Exclusion criteria: Not willing to provide consent. Inclusion Criteria for Patients: * Age ≥ 18 years * Having a cancer diagnosis * Likely self-identifying as a Chinese, Japanese, or Korean American/immigrant * Being able to read and respond to questions in either English, Mandarin, Japanese, Korean, or Chinese dialects, such as Cantonese, Shanghai, Taishanese, or Taiwanese. Exclusion Criteria for Patients: * Having cognitive impairment per the Short Portable Mental Status Questionnaire with more than three errors Inclusion Criteria for Family Caregivers: * Age ≥ 18 years * Being able to read and respond to questions in either English, Mandarin, Japanese, Korean, or Chinese dialects, such as Cantonese, Shanghai, Taishanese, or Taiwanese * Having a family member who is likely to self-identify as a Chinese, Japanese, or Korean American/immigrant and has been diagnosed with cancer
Contact & Investigator
Li-Ting H. Longcoy
PRINCIPAL INVESTIGATOR
University of Illinois Chicago College of Nursing
Frequently Asked Questions
Who can join the NCT06035549 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Neoplasms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06035549 currently recruiting?
Yes, NCT06035549 is actively recruiting participants. Contact the research team at liting@uic.edu for enrollment information.
Where is the NCT06035549 trial being conducted?
This trial is being conducted at Chicago, United States.
Who is sponsoring the NCT06035549 clinical trial?
NCT06035549 is sponsored by University of Illinois at Chicago. The principal investigator is Li-Ting H. Longcoy at University of Illinois Chicago College of Nursing. The trial plans to enroll 84 participants.